The Werff Report
18 Oct 2021
FDA Delays Moderna Approval In Adolescents Due To Concerns While Pfizer Deaths Are Nearly Triple
28
0
The corrupt U.S. Food and Drug Administration has decided to delay its decision on approving the Moderna Pfizer vaccine for use in adolescents, citing concerns of a higher risk for heart condition.
Show more
The simplest answer is money. Apparently, Phizer makes up 75% of the FDA's funding, so the bias is pretty obvious.
Pfizer has been buying out companies for years and acquiring their patents and proprietary formulas. In October 2016, the company licensed the anti-CTLA4 monoclonal antibody, ONC-392, from OncoImmune. In August 2018, Pfizer signed an agreement with BioNTech to conduct joint research and development activities regarding mRNA-based influenza vaccines. In July 2020, Pfizer and BioNTech announced that two of the partners' four mRNA vaccine candidates had won fast track designation from the FDA. Pfizer owns the market and wants to be the #1 supplier of the Scamdemic Vaccine. It sure looks like grift, graft, and corruption. How deep does this go?
Kickbacks. Kickbacks
It looks like the Pfizer vaccine is doing exactly what they want.